Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Wisconsin for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Wisconsin only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Wisconsin (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Steven Bettag (NPI 1669529608)

Field	Value
Entity Type	Individual
Organization	Steven Bettag
Address	1621 N Taylor Dr
City	Sheboygan
State	WI
ZIP	53081
Taxonomy	Medical Oncology Physician
NPI Enumerated	January 4, 2007

Payer Source	Total Paid
Medicare	$872.6K
Medicaid	$0

Key Findings

STEVEN BETTAG is a long-tenured Medical Oncology Physician with an NPI enumerated on 2007-01-04 (~19 years ago), indicating nearly two decades of Medicare billing history and likely established practice patterns in SHEBOYGAN, WI. This tenure supports interpretation of the observed procedure mix as reflective of a mature oncology outpatient practice rather than a new or temporary provider.

This provider’s lifetime Medicare revenue is $872.6K while there is no Medicaid billing on file, making STEVEN BETTAG effectively a single-payer (Medicare) billing entity in the available data; analysts should treat Medicaid-derived insights as not applicable.

Revenue is highly concentrated in a small number of Medicare codes: the top 3 Medicare codes by revenue account for 55.6% of total Medicare revenue, signaling dependence on a few high-revenue commodity services. Given that J9312 (rituximab) alone accounts for $295.5K (36.1% of Medicare revenue), a large share of revenue derives from high-cost drug administration.

The code mix and descriptions point to a chemotherapy/infusion-focused oncology practice: large volumes of injection and infusion drug codes such as J9312 (rituximab), J0897 (denosumab), and multiple chemotherapy administration codes (96413, 96365, 96367, 96415, 96417) illustrate routine outpatient chemotherapy and supportive care infusions as primary service lines. Frequent use of E/M codes 99214 and 99215 alongside infusion codes suggests the practice combines high-acuity office visits with infusion suites rather than just procedural billing.

Competitive standing by code is mixed: for J9312 the provider ranks #81 of 317 nationally (75th percentile), indicating somewhat above-typical national participation but not dominance; J0897 ranks #3091 of 10057 (69th percentile), also typical for national peers. In contrast, evaluation-and-management code usage is relatively elevated—99214 ranks at the 97th percentile and 99215 at the 99th percentile—marking the provider as a national high-volume outlier for higher-complexity E/M visits.

Several codes are statistical outliers in different directions and merit attention operationally: 99215 is labeled an "extreme outlier, far above typical national volume," which suggests unusually high billing of high-complexity established-patient visits relative to peers; 99214 is "notably above typical national volume," reinforcing elevated office-based complexity and time intensity. Conversely, many drug administration and lab codes are in typical percentiles, indicating expected oncology practice patterns rather than anomalous drug mix.

Service mix details reinforce that high-revenue drug administration is the main revenue driver: J9312 ($295.5K, 36.1%) and J0897 ($82.1K, 10.0%) together with 99214/99215 make up the precomputed top-3 concentration, underscoring that rituximab infusions and associated high-complexity visits are central to the business model. This concentration creates sensitivity in revenue to utilization or pricing changes for those drugs.

Operational throughput appears significant in ancillary services consistent with infusion clinics: high claim counts for items like 4.7K claims for J9312, 4.6K claims for J0897, and thousands of basic lab/service claims (e.g., 1.4K claims for 80053, 1.6K for 85025) imply steady outpatient flow and integrated lab testing supporting infusion care. Payers and network managers should interpret this as a practice combining frequent drug administration with routine monitoring labs.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

71 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9312	Injection, rituximab, 10 mg	4,690	$60	$295.5K
J0897	Injection, denosumab, 1 mg	4,560	$20	$82.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	870	$90	$77.2K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	540	$130	$71.5K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	1,500	$40	$54K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	390	$100	$38.5K
J1437	Injection, ferric derisomaltose, 10 mg	1,900	$20	$32.3K
J3315	Injection, triptorelin pamoate, 3.75 mg	100	$290	$30.3K
J3490	Unclassified drugs	330	$70	$22.2K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	1,380	$10	$13.8K

Showing 1–10 of 71

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 71 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Wisconsin Distribution

Steven Bettag — 11 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Wisconsin

Full comparison — all codes billed, vs. state median

71 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9312	3	10	2,580	$60	$234.8K
J1569	3	10	4,600	$40	$201.8K
J0897	10	60	2,220	$20	$69.3K
J1437	1	10	1,900	$20	$31.9K
Q5125	2	10	54,090	$1	$25K
J3315	1	10	80	$290	$24.3K
J3490	1	10	30	$260	$22.4K
83880	29	40	30	$40	$16.8K
82306	51	120	20	$30	$13.1K
96413	4	80	110	$90	$12.7K

Showing 1–10 of 71

Related Providers

Other providers that share a Tax Identification Number (TIN) with Steven Bettag, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
H Matthews	WI	Hematology & Oncology Physician	$685.2K	$0
Michael Johnson	WI	Internal Medicine Physician	$137.7K	$0
Nicholas Barnes	WI	Internal Medicine Physician	$137.5K	$0
Matthew Hemsing	WI	Internal Medicine Physician	$134.7K	$0

Nearby Providers

Other providers in the same ZIP code as Steven Bettag, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Vista Care South Dakota, LLC	WI	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$20M
Sheboygan County Health & Human Services	WI	Community/Behavioral Health Agency	$0	$19.3M
Lakeshore Community Health Care, Inc	WI	Federally Qualified Health Center (FQHC)	$0	$14.7M
Aurora Health Care Central, Inc.	WI	General Acute Care Hospital	$0	$12.4M
Universal Home Health Care, Inc	WI	Home Health Agency	$0	$11.6M
St. Nicholas Hospital-sisters Of The Third Order Of St Francis	WI	General Acute Care Hospital	$0	$5M
Sheboygan County Health & Human Services	WI	Case Management Agency	$0	$4.1M
Sheboygan Area School District	WI	Local Education Agency (LEA)	$0	$3.9M
William Shows	WI	Orthodontics and Dentofacial Orthopedics Dentistry	$0	$3.9M
Hospice Advantage, LLC	WI	Community Based Hospice Care Agency	$0	$3.6M

Steven Bettag — Billing Profile & Reimbursement Data

Sign up for Steven Bettag — Billing Profile & Reimbursement Data policy alerts

Steven Bettag — Billing Profile & Reimbursement Data

Sign up for Steven Bettag — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References